1 week Ago By [email protected] (MENAFN)
Dublin, April 07, 2025 (GLOBE NEWSWIRE) -- The "Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions" report has been added to ResearchAndMarkets.com's offering. Both qualitative and quantitative data on the current dynamics impacting the global cancer therapeutics market are presented in this report.
It discusses the history of cancer, its different forms, its pathophysiology, its stages of development and its mechanisms of metastasis and recurrence. It also incorporates the disease burden by knowing the epidemiology of different cancers. Treatment patterns that include both non-pharmacological (e.
g., radiation, surgery) and pharmacological (e.g.
, hormonal therapy, targeted therapy, cytotoxic/chemotherapy, combinatorial therapy) approaches are discussed to illustrate the various therapeutic options available to patients. Analyses of the most popular products, the state of clinical trials and new product approvals are also included in the report. The demographics of the major regions - North America, Europe, Asia-Pacific and the Rest of the World - as well as their prospects for growth, are summarized.
The profiles of leading companies and the strategies of international businesses involved in the cancer treatment sector are also discussed. Estimations of the market size for therapies that treat cancer metastases and recurrence states are included in the scope. The global market for cancer therapeutics emphasizing recurrent and metastatic divisions is expected to grow from $116.
1 billion in 2024 to reach $168 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2029. The global cancer therapeutics market emphasis on recurrent and metastatic divisions was valued at $108.
1 billion in 2023. The market is expected to grow at a compound annual growth rate (CAGR) of 7.7% to reach $168 billion by the end of 2029.
There are several reasons why the oncology pharmaceutical sector is a promising one for growth. The dynamic and quickly changing oncology pharmaceutical market is a part of the global pharmaceutical industry. The development, manufacturing and distribution of medications used to treat cancer are the main objectives of this market, which is anticipated to keep expanding considering the continuous developments in science and technology.
Novel immunotherapies and CAR-T cell therapy are two emerging treatments that could completely change the way cancer is treated. The accessibility and affordability of medications must be addressed to ensure that new treatments benefit a wide range of patients. The movement of cancer cells from their original locations to different areas of the body is known as "metastasis" or "metastatic cancer.
" Cancer cells separate from the original tumor during metastasis, move through the blood or lymphatic system and develop into a new tumor in different body tissues or organs. The primary tumor and the new metastatic tumor are the same type of cancer. Breast cancer cells, not lung cancer cells, are present in the lung if the disease spreads there.
Compared to localized cancers, metastatic cancer usually has a worse prognosis, and it is more challenging to treat. Given the aggressive nature of metastatic disease and the difficulty of overcoming resistance to current therapies, there is a significant need for novel treatments for metastatic cancers, making this market crucial. There are more metastatic cases due to patients living longer after initial treatment due to advances in cancer detection and treatment.
Approximately 90% of cancer-related deaths are thought to be caused by metastases (Chaffer CL et al., Science, 2011). With the advent of combination therapies, which combine immunotherapy, targeted therapy and chemotherapy to boost efficacy and overcome resistance, the market for treatments for metastatic cancer is rapidly changing.
Genetic profiling and biomarker testing enable treatments specific to each patient's cancer type and mutations, so personalized medicine is increasingly playing a crucial role in the treatment of metastatic cancers. Cancer types noted in this report include: Additional growth potential and forecast data are discussed for the cancer therapeutics market, as well as for the cancer types, regions and countries. For market estimates, data are provided for 2023 as the base year, with forecasts for the period of 2024 through 2029.
Report Scope: Key Attributes: Key Topics Covered: Chapter 1 Executive Summary Chapter 2 Market Overview Chapter 3 Market Dynamics Chapter 4 Regulatory Landscape Chapter 5 Emerging Trends and Pipeline Analysis Chapter 6 Supply Chain Analysis Chapter 7 Market Segmentation Analysis Chapter 8 Competitive Intelligence Chapter 9 Sustainability in Cancers Therapeutics Market Emphasis on Recurrent and Metastatic Divisions: ESG Perspective Company Profiles For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. MENAFN07042025004107003653ID1109397866 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind.
We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above..
